Phathom Pharmaceuticals Stock Price History

PHAT Stock  USD 6.23  0.03  0.48%   
Below is the normalized historical share price chart for Phathom Pharmaceuticals extending back to October 25, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Phathom Pharmaceuticals stands at 6.23, as last reported on the 22nd of March, with the highest price reaching 6.54 and the lowest price hitting 6.06 during the day.
IPO Date
25th of October 2019
200 Day MA
11.0342
50 Day MA
5.9094
Beta
0.636
 
Covid
If you're considering investing in Phathom Stock, it is important to understand the factors that can impact its price. Phathom Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0261, which implies the firm had a -0.0261 % return per unit of risk over the last 3 months. Phathom Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Phathom Pharmaceuticals' Variance of 33.14, risk adjusted performance of (0.02), and Coefficient Of Variation of (3,002) to confirm the risk estimate we provide.
  
Total Stockholder Equity is likely to gain to about (240.9 M) in 2025. Common Stock Shares Outstanding is likely to drop to about 40.4 M in 2025. Price To Sales Ratio is likely to drop to 8.82 in 2025. Price Earnings Ratio is likely to drop to -1.61 in 2025. Phathom Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0261

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPHAT

Estimated Market Risk

 5.9
  actual daily
52
52% of assets are less volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average Phathom Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Phathom Pharmaceuticals by adding Phathom Pharmaceuticals to a well-diversified portfolio.
Price Book
25.3678
Enterprise Value Ebitda
(2.20)
Price Sales
7.9216
Shares Float
56.7 M
Wall Street Target Price
21.125

Phathom Pharmaceuticals Stock Price History Chart

There are several ways to analyze Phathom Stock price data. The simplest method is using a basic Phathom candlestick price chart, which shows Phathom Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 27, 20248.18
Lowest PriceMarch 13, 20254.22

Phathom Pharmaceuticals March 22, 2025 Stock Price Synopsis

Various analyses of Phathom Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Phathom Stock. It can be used to describe the percentage change in the price of Phathom Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Phathom Stock.
Phathom Pharmaceuticals Price Action Indicator(0.08)
Phathom Pharmaceuticals Price Rate Of Daily Change 1.00 
Phathom Pharmaceuticals Price Daily Balance Of Power(0.06)

Phathom Pharmaceuticals March 22, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Phathom Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Phathom Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Phathom Stock and then apply it to test your longer-term investment strategies against Phathom.

Phathom Stock Price History Data

The price series of Phathom Pharmaceuticals for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 4.15 with a coefficient of variation of 16.62. The price distribution for the period has arithmetic mean of 6.37. The median price for the last 90 days is 6.25.
OpenHighLowCloseVolume
03/22/2025
 6.14  6.54  6.06  6.23 
03/21/2025 6.14  6.54  6.06  6.23  1,517,105 
03/20/2025 6.01  6.31  5.92  6.26  1,804,790 
03/19/2025 5.68  6.16  5.47  6.08  1,650,021 
03/18/2025 5.02  5.85  4.98  5.54  2,406,901 
03/17/2025 4.42  4.89  4.40  4.84  921,898 
03/14/2025 4.24  4.48  4.07  4.41  1,241,742 
03/13/2025 4.99  5.05  4.18  4.22  1,422,321 
03/12/2025 4.83  5.25  4.62  5.00  1,532,389 
03/11/2025 4.41  4.85  4.33  4.79  1,588,667 
03/10/2025 5.02  5.08  4.35  4.40  1,822,086 
03/07/2025 5.77  5.77  5.01  5.06  1,816,413 
03/06/2025 5.76  6.98  5.35  5.90  2,346,316 
03/05/2025 5.65  6.21  5.64  6.08  1,027,249 
03/04/2025 5.15  5.61  5.07  5.58  863,155 
03/03/2025 5.48  5.91  5.15  5.21  1,046,179 
02/28/2025 5.68  5.74  5.36  5.52  946,960 
02/27/2025 5.80  5.87  5.62  5.76  664,592 
02/26/2025 5.71  6.18  5.67  5.79  1,208,165 
02/25/2025 5.34  5.70  5.31  5.58  989,743 
02/24/2025 5.67  5.70  5.31  5.34  1,219,659 
02/21/2025 5.59  5.76  5.53  5.67  723,073 
02/20/2025 5.76  5.76  5.50  5.54  639,106 
02/19/2025 5.78  5.91  5.58  5.76  846,540 
02/18/2025 5.73  6.02  5.52  5.72  1,182,265 
02/14/2025 6.00  6.21  5.75  5.77  1,236,280 
02/13/2025 5.50  5.82  5.41  5.62  645,747 
02/12/2025 5.30  5.55  5.26  5.48  831,359 
02/11/2025 5.33  5.52  5.21  5.39  804,033 
02/10/2025 5.75  5.75  5.30  5.41  1,042,407 
02/07/2025 5.90  5.92  5.51  5.71  1,011,421 
02/06/2025 6.31  6.36  5.90  5.90  657,175 
02/05/2025 6.05  6.40  5.96  6.34  727,589 
02/04/2025 5.66  6.06  5.42  6.05  1,296,799 
02/03/2025 5.78  6.01  5.58  5.63  2,057,784 
01/31/2025 6.31  6.33  5.95  5.99  1,460,704 
01/30/2025 6.59  6.63  6.21  6.34  1,309,976 
01/29/2025 6.28  6.59  6.20  6.55  795,118 
01/28/2025 6.55  6.60  6.18  6.25  1,109,528 
01/27/2025 7.00  7.01  6.47  6.56  1,050,359 
01/24/2025 7.15  7.25  6.71  6.90  1,144,065 
01/23/2025 6.97  7.19  6.75  7.17  649,286 
01/22/2025 6.79  7.10  6.79  6.99  864,636 
01/21/2025 6.95  6.98  6.35  6.79  2,113,513 
01/17/2025 6.98  7.05  6.78  6.96  754,613 
01/16/2025 7.15  7.20  6.74  6.96  871,496 
01/15/2025 6.97  7.15  6.64  7.13  743,851 
01/14/2025 6.68  6.83  6.42  6.79  873,633 
01/13/2025 6.78  6.90  6.36  6.62  1,191,003 
01/10/2025 6.91  7.11  6.73  6.94  995,738 
01/08/2025 7.12  7.19  6.82  6.95  842,801 
01/07/2025 7.69  7.78  7.16  7.20  841,958 
01/06/2025 7.74  7.91  7.55  7.61  627,172 
01/03/2025 7.38  7.79  7.34  7.74  816,568 
01/02/2025 8.18  8.34  7.33  7.33  1,017,023 
12/31/2024 7.99  8.33  7.85  8.12  1,009,222 
12/30/2024 8.16  8.29  7.80  8.00  799,617 
12/27/2024 8.08  8.22  7.85  8.18  848,664 
12/26/2024 7.51  8.31  7.40  8.10  1,119,398 
12/24/2024 7.59  7.72  7.21  7.50  401,705 
12/23/2024 7.42  7.65  7.03  7.61  950,212 

About Phathom Pharmaceuticals Stock history

Phathom Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Phathom is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Phathom Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Phathom Pharmaceuticals stock prices may prove useful in developing a viable investing in Phathom Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding63.2 M40.4 M
Net Loss-178 M-186.8 M

Phathom Pharmaceuticals Quarterly Net Working Capital

274.41 Million

Phathom Pharmaceuticals Stock Technical Analysis

Phathom Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Phathom Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Phathom Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Phathom Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Phathom Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Phathom Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Phathom to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Phathom Stock Analysis

When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.